The global Women's Health Care Drugs market was valued at US$ 32800 million in 2022 and is projected to reach US$ 42120 million by 2029, at a CAGR of 3.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Women's Health Care Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Women's Health Care Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Women's Health Care Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report focuses on pharmaceutical products for female-related diseases.
This report aims to provide a comprehensive presentation of the global market for Women's Health Care Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women's Health Care Drugs.
This report contains market size and forecasts of Women's Health Care Drugs in global, including the following market information:
- Global Women's Health Care Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.
We has surveyed the Women's Health Care Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Women's Health Care Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Women's Health Care Drugs Market Segment Percentages, by Type, 2022 (%)
- Hormonal Infertility
- Postmenopausal Osteoporosis
- Endometriosis
- Contraceptives
- Menopause
- Polycystic Ovary Syndrome
- Others
Global Women's Health Care Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Women's Health Care Drugs Market Segment Percentages, by Application, 2022 (%)
- Prescription Drugs
- Non-prescription Drugs
Global Women's Health Care Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Women's Health Care Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Women's Health Care Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Women's Health Care Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer AG
- Allergan
- Merck & Co
- Pfizer Inc.
- Amgen
- Agile Therapeutics
- Ferring Pharmaceuticals
- Mylan N.V.
- Lupin
- Blairex Laboratories
- Apothecus Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Women's Health Care Drugs, market overview.
Chapter 2: Global Women's Health Care Drugs market size in revenue.
Chapter 3: Detailed analysis of Women's Health Care Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Women's Health Care Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Women's Health Care Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Women's Health Care Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Women's Health Care Drugs Overall Market Size
2.1 Global Women's Health Care Drugs Market Size: 2022 VS 2030
2.2 Global Women's Health Care Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Women's Health Care Drugs Players in Global Market
3.2 Top Global Women's Health Care Drugs Companies Ranked by Revenue
3.3 Global Women's Health Care Drugs Revenue by Companies
3.4 Top 3 and Top 5 Women's Health Care Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Women's Health Care Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Women's Health Care Drugs Players in Global Market
3.6.1 List of Global Tier 1 Women's Health Care Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Women's Health Care Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Women's Health Care Drugs Market Size Markets, 2022 & 2030
4.1.2 Hormonal Infertility
4.1.3 Postmenopausal Osteoporosis
4.1.4 Endometriosis
4.1.5 Contraceptives
4.1.6 Menopause
4.1.7 Polycystic Ovary Syndrome
4.1.8 Others
4.2 By Type - Global Women's Health Care Drugs Revenue & Forecasts
4.2.1 By Type - Global Women's Health Care Drugs Revenue, 2018-2023
4.2.2 By Type - Global Women's Health Care Drugs Revenue, 2024-2030
4.2.3 By Type - Global Women's Health Care Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Women's Health Care Drugs Market Size, 2022 & 2030
5.1.2 Prescription Drugs
5.1.3 Non-prescription Drugs
5.2 By Application - Global Women's Health Care Drugs Revenue & Forecasts
5.2.1 By Application - Global Women's Health Care Drugs Revenue, 2018-2023
5.2.2 By Application - Global Women's Health Care Drugs Revenue, 2024-2030
5.2.3 By Application - Global Women's Health Care Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Women's Health Care Drugs Market Size, 2022 & 2030
6.2 By Region - Global Women's Health Care Drugs Revenue & Forecasts
6.2.1 By Region - Global Women's Health Care Drugs Revenue, 2018-2023
6.2.2 By Region - Global Women's Health Care Drugs Revenue, 2024-2030
6.2.3 By Region - Global Women's Health Care Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Women's Health Care Drugs Revenue, 2018-2030
6.3.2 US Women's Health Care Drugs Market Size, 2018-2030
6.3.3 Canada Women's Health Care Drugs Market Size, 2018-2030
6.3.4 Mexico Women's Health Care Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Women's Health Care Drugs Revenue, 2018-2030
6.4.2 Germany Women's Health Care Drugs Market Size, 2018-2030
6.4.3 France Women's Health Care Drugs Market Size, 2018-2030
6.4.4 U.K. Women's Health Care Drugs Market Size, 2018-2030
6.4.5 Italy Women's Health Care Drugs Market Size, 2018-2030
6.4.6 Russia Women's Health Care Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Women's Health Care Drugs Market Size, 2018-2030
6.4.8 Benelux Women's Health Care Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Women's Health Care Drugs Revenue, 2018-2030
6.5.2 China Women's Health Care Drugs Market Size, 2018-2030
6.5.3 Japan Women's Health Care Drugs Market Size, 2018-2030
6.5.4 South Korea Women's Health Care Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Women's Health Care Drugs Market Size, 2018-2030
6.5.6 India Women's Health Care Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Women's Health Care Drugs Revenue, 2018-2030
6.6.2 Brazil Women's Health Care Drugs Market Size, 2018-2030
6.6.3 Argentina Women's Health Care Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Women's Health Care Drugs Revenue, 2018-2030
6.7.2 Turkey Women's Health Care Drugs Market Size, 2018-2030
6.7.3 Israel Women's Health Care Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Women's Health Care Drugs Market Size, 2018-2030
6.7.5 UAE Women's Health Care Drugs Market Size, 2018-2030
7 Women's Health Care Drugs Companies Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Women's Health Care Drugs Major Product Offerings
7.1.4 Bayer AG Women's Health Care Drugs Revenue in Global Market (2018-2023)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Women's Health Care Drugs Major Product Offerings
7.2.4 Allergan Women's Health Care Drugs Revenue in Global Market (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 Merck & Co
7.3.1 Merck & Co Company Summary
7.3.2 Merck & Co Business Overview
7.3.3 Merck & Co Women's Health Care Drugs Major Product Offerings
7.3.4 Merck & Co Women's Health Care Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck & Co Key News & Latest Developments
7.4 Pfizer Inc.
7.4.1 Pfizer Inc. Company Summary
7.4.2 Pfizer Inc. Business Overview
7.4.3 Pfizer Inc. Women's Health Care Drugs Major Product Offerings
7.4.4 Pfizer Inc. Women's Health Care Drugs Revenue in Global Market (2018-2023)
7.4.5 Pfizer Inc. Key News & Latest Developments
7.5 Amgen
7.5.1 Amgen Company Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Women's Health Care Drugs Major Product Offerings
7.5.4 Amgen Women's Health Care Drugs Revenue in Global Market (2018-2023)
7.5.5 Amgen Key News & Latest Developments
7.6 Agile Therapeutics
7.6.1 Agile Therapeutics Company Summary
7.6.2 Agile Therapeutics Business Overview
7.6.3 Agile Therapeutics Women's Health Care Drugs Major Product Offerings
7.6.4 Agile Therapeutics Women's Health Care Drugs Revenue in Global Market (2018-2023)
7.6.5 Agile Therapeutics Key News & Latest Developments
7.7 Ferring Pharmaceuticals
7.7.1 Ferring Pharmaceuticals Company Summary
7.7.2 Ferring Pharmaceuticals Business Overview
7.7.3 Ferring Pharmaceuticals Women's Health Care Drugs Major Product Offerings
7.7.4 Ferring Pharmaceuticals Women's Health Care Drugs Revenue in Global Market (2018-2023)
7.7.5 Ferring Pharmaceuticals Key News & Latest Developments
7.8 Mylan N.V.
7.8.1 Mylan N.V. Company Summary
7.8.2 Mylan N.V. Business Overview
7.8.3 Mylan N.V. Women's Health Care Drugs Major Product Offerings
7.8.4 Mylan N.V. Women's Health Care Drugs Revenue in Global Market (2018-2023)
7.8.5 Mylan N.V. Key News & Latest Developments
7.9 Lupin
7.9.1 Lupin Company Summary
7.9.2 Lupin Business Overview
7.9.3 Lupin Women's Health Care Drugs Major Product Offerings
7.9.4 Lupin Women's Health Care Drugs Revenue in Global Market (2018-2023)
7.9.5 Lupin Key News & Latest Developments
7.10 Blairex Laboratories
7.10.1 Blairex Laboratories Company Summary
7.10.2 Blairex Laboratories Business Overview
7.10.3 Blairex Laboratories Women's Health Care Drugs Major Product Offerings
7.10.4 Blairex Laboratories Women's Health Care Drugs Revenue in Global Market (2018-2023)
7.10.5 Blairex Laboratories Key News & Latest Developments
7.11 Apothecus Pharmaceutical
7.11.1 Apothecus Pharmaceutical Company Summary
7.11.2 Apothecus Pharmaceutical Business Overview
7.11.3 Apothecus Pharmaceutical Women's Health Care Drugs Major Product Offerings
7.11.4 Apothecus Pharmaceutical Women's Health Care Drugs Revenue in Global Market (2018-2023)
7.11.5 Apothecus Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Women's Health Care Drugs Market Opportunities & Trends in Global Market
Table 2. Women's Health Care Drugs Market Drivers in Global Market
Table 3. Women's Health Care Drugs Market Restraints in Global Market
Table 4. Key Players of Women's Health Care Drugs in Global Market
Table 5. Top Women's Health Care Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Women's Health Care Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Women's Health Care Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Women's Health Care Drugs Product Type
Table 9. List of Global Tier 1 Women's Health Care Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Women's Health Care Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Women's Health Care Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Women's Health Care Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Women's Health Care Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Women's Health Care Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Women's Health Care Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Women's Health Care Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Women's Health Care Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Women's Health Care Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Women's Health Care Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Women's Health Care Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Women's Health Care Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Women's Health Care Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Women's Health Care Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Women's Health Care Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Women's Health Care Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Women's Health Care Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Women's Health Care Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Women's Health Care Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Women's Health Care Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Bayer AG Company Summary
Table 31. Bayer AG Women's Health Care Drugs Product Offerings
Table 32. Bayer AG Women's Health Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer AG Key News & Latest Developments
Table 34. Allergan Company Summary
Table 35. Allergan Women's Health Care Drugs Product Offerings
Table 36. Allergan Women's Health Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Allergan Key News & Latest Developments
Table 38. Merck & Co Company Summary
Table 39. Merck & Co Women's Health Care Drugs Product Offerings
Table 40. Merck & Co Women's Health Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Merck & Co Key News & Latest Developments
Table 42. Pfizer Inc. Company Summary
Table 43. Pfizer Inc. Women's Health Care Drugs Product Offerings
Table 44. Pfizer Inc. Women's Health Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Inc. Key News & Latest Developments
Table 46. Amgen Company Summary
Table 47. Amgen Women's Health Care Drugs Product Offerings
Table 48. Amgen Women's Health Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Agile Therapeutics Company Summary
Table 51. Agile Therapeutics Women's Health Care Drugs Product Offerings
Table 52. Agile Therapeutics Women's Health Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Agile Therapeutics Key News & Latest Developments
Table 54. Ferring Pharmaceuticals Company Summary
Table 55. Ferring Pharmaceuticals Women's Health Care Drugs Product Offerings
Table 56. Ferring Pharmaceuticals Women's Health Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Ferring Pharmaceuticals Key News & Latest Developments
Table 58. Mylan N.V. Company Summary
Table 59. Mylan N.V. Women's Health Care Drugs Product Offerings
Table 60. Mylan N.V. Women's Health Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Mylan N.V. Key News & Latest Developments
Table 62. Lupin Company Summary
Table 63. Lupin Women's Health Care Drugs Product Offerings
Table 64. Lupin Women's Health Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Lupin Key News & Latest Developments
Table 66. Blairex Laboratories Company Summary
Table 67. Blairex Laboratories Women's Health Care Drugs Product Offerings
Table 68. Blairex Laboratories Women's Health Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Blairex Laboratories Key News & Latest Developments
Table 70. Apothecus Pharmaceutical Company Summary
Table 71. Apothecus Pharmaceutical Women's Health Care Drugs Product Offerings
Table 72. Apothecus Pharmaceutical Women's Health Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Apothecus Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Women's Health Care Drugs Segment by Type in 2022
Figure 2. Women's Health Care Drugs Segment by Application in 2022
Figure 3. Global Women's Health Care Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Women's Health Care Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Women's Health Care Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Women's Health Care Drugs Revenue in 2022
Figure 8. By Type - Global Women's Health Care Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Women's Health Care Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Women's Health Care Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Women's Health Care Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Women's Health Care Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Women's Health Care Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Women's Health Care Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Women's Health Care Drugs Revenue Market Share, 2018-2030
Figure 16. US Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Women's Health Care Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Women's Health Care Drugs Revenue Market Share, 2018-2030
Figure 28. China Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Women's Health Care Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Women's Health Care Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Women's Health Care Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Bayer AG Women's Health Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Allergan Women's Health Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck & Co Women's Health Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Inc. Women's Health Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Amgen Women's Health Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Agile Therapeutics Women's Health Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Ferring Pharmaceuticals Women's Health Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Mylan N.V. Women's Health Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Lupin Women's Health Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Blairex Laboratories Women's Health Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Apothecus Pharmaceutical Women's Health Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
